Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities (Q35000581)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 6, 2010

Language	Label	Description	Also known as
English	Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities	scientific article published on October 6, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities (English)

1 reference

10.1016/J.BBMT.2010.09.018

https://api.crossref.org/works/10.1016/J.BBMT.2010.09.018

29 July 2024

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic myelomonocytic leukemia

1 reference

based on heuristic

inferred from title

transplantation conditioning

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20932924

29 July 2024

13

object named as

Rainer Storb

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Brenda M Sandmaier

11

object named as

Brenda M Sandmaier

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Frederick R. Appelbaum

14

object named as

Frederick R Appelbaum

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Hans Joachim Deeg

15

object named as

H Joachim Deeg

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

8

object named as

Paul J Martin

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Mohamed L Sorror

3

object named as

Mohamed L Sorror

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

5

object named as

Bart L Scott

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Kristine C Doney

6

object named as

Kristine Doney

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

10

object named as

Jerry P Radich

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

12

object named as

E. Houston Warren

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20932924

29 July 2024

author name string

Hesham Eissa

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Franchesca Nguyen

4

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Ted A. Gooley

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20932924

29 July 2024

Kristine Doney

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20932924

29 July 2024

Keith R. Loeb

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20932924

29 July 2024

John M. Pagel

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20932924

29 July 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20932924

29 July 2024

publication date

6 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

full work available at URL

http://www.bbmt.org/article/S1083879110004143/pdf

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20932924

29 July 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20932924/?tool=EBI

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20932924

29 July 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20932924/pdf/?tool=EBI

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20932924

29 July 2024

https://europepmc.org/articles/PMC3100432

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20932924

29 July 2024

https://europepmc.org/articles/PMC3100432?pdf=render

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20932924

29 July 2024

https://doi.org/10.1016/j.bbmt.2010.09.018

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20932924

29 July 2024

https://api.elsevier.com/content/article/PII:S1083879110004143?httpAccept=text/xml

1 reference

10.1016/J.BBMT.2010.09.018

https://api.crossref.org/works/10.1016/J.BBMT.2010.09.018

29 July 2024

https://api.elsevier.com/content/article/PII:S1083879110004143?httpAccept=text/plain

1 reference

10.1016/J.BBMT.2010.09.018

https://api.crossref.org/works/10.1016/J.BBMT.2010.09.018

29 July 2024

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

908-915

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

26 October 2018

[Clinical features of a new category, myelodysplastic/myeloproliferative diseases, defined by WHO classification].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

26 October 2018

Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

26 October 2018

Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

26 October 2018

Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

26 October 2018

Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

26 October 2018

Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

26 October 2018

Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient

1 reference

https://pubmed.ncbi.nlm.nih.gov/20932924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20932924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20932924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20932924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20932924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic myelomonocytic leukemia in the light of the WHO proposals

1 reference

https://pubmed.ncbi.nlm.nih.gov/20932924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A New Prognostic Scoring System Including Transfusion Dependency and Cytogenetic Abnormalities for Patients with Chronic Myelomonocytic Leukemia.

7

1 reference

10.1016/J.BBMT.2010.09.018

https://api.crossref.org/works/10.1016/J.BBMT.2010.09.018

29 July 2024

Risk Factors for the Development of Acute and National Institute of Health (NIH) Chronic Graft-Versus-Host Disease (GVHD).

22

1 reference

10.1016/J.BBMT.2010.09.018

https://api.crossref.org/works/10.1016/J.BBMT.2010.09.018

29 July 2024

Identifiers

10.1016/J.BBMT.2010.09.018

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35000581&oldid=2215685642"